Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Glibenclamide
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Glibenclamide 5mg tablets
0601021H0AAABAB
|
Glibenclamide | Glibenclamide | Endocrine System | 15 |
|
Glibenclamide 2.5mg tablets
0601021H0AAAAAA
|
Glibenclamide | Glibenclamide | Endocrine System | 13 |
|
Glibenclamide 5mg/5ml oral liquid
0601021H0AAAJAJ
|
Glibenclamide | Glibenclamide | Endocrine System | 6 |
|
Amglidia 0.6mg/ml oral suspension with 1ml oral syringe
0601021H0BNAAAP
|
Amglidia | Glibenclamide | Endocrine System | No data available |
|
Amglidia 0.6mg/ml oral suspension with 5ml oral syringe
0601021H0BNABAP
|
Amglidia | Glibenclamide | Endocrine System | No data available |
|
Amglidia 6mg/ml oral suspension with 1ml oral syringe
0601021H0BNACAQ
|
Amglidia | Glibenclamide | Endocrine System | No data available |
|
Amglidia 6mg/ml oral suspension with 5ml oral syringe
0601021H0BNADAQ
|
Amglidia | Glibenclamide | Endocrine System | No data available |
|
Daonil 5mg tablets
0601021H0BBAAAB
|
Daonil | Glibenclamide | Endocrine System | No data available |
|
Diabetamide 2.5mg tablets
0601021H0BKAAAA
|
Diabetamide | Glibenclamide | Endocrine System | No data available |
|
Diabetamide 5mg tablets
0601021H0BKABAB
|
Diabetamide | Glibenclamide | Endocrine System | No data available |
|
Euglucon 2.5mg tablets
0601021H0BDAAAA
|
Euglucon | Glibenclamide | Endocrine System | No data available |
|
Euglucon 5mg tablets
0601021H0BDABAB
|
Euglucon | Glibenclamide | Endocrine System | No data available |
|
Glibenclamide 15mg/5ml oral liquid
0601021H0AAAMAM
|
Glibenclamide | Glibenclamide | Endocrine System | No data available |
|
Glibenclamide 2.5mg/5ml oral liquid
0601021H0AAAKAK
|
Glibenclamide | Glibenclamide | Endocrine System | No data available |
|
Glibenclamide 600micrograms/ml oral suspension sugar free
0601021H0AAAPAP
|
Glibenclamide | Glibenclamide | Endocrine System | No data available |
|
Glibenclamide 625micrograms/5ml oral liquid
0601021H0AAAIAI
|
Glibenclamide | Glibenclamide | Endocrine System | No data available |
|
Glibenclamide 6mg/ml oral suspension sugar free
0601021H0AAAQAQ
|
Glibenclamide | Glibenclamide | Endocrine System | No data available |
|
Glibenclamide 7.5mg/5ml oral liquid
0601021H0AAANAN
|
Glibenclamide | Glibenclamide | Endocrine System | No data available |
|
Semi-Daonil 2.5mg tablets
0601021H0BBACAA
|
Daonil | Glibenclamide | Endocrine System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.